Recent Posts

Post thread…


Sick of Syneos Rep Not Working - AstraZeneca

  • I don't even blame them, AZ just keeps dangling the carrot knowing the large majority of them will never be rolled over. There's a high turnover rate happening at the contract level right now, they're finally seeing what's happening and those who can are securing other jobs

anonymous
May 20, 2025 at 12:37 PM
B.F. - Bausch & Lomb
anonymous
May 20, 2025 at 12:34 PM
Core 4 - Novartis

  • anonymous said:
    Things that make you go hmmm.

    Does anyone else see what is going on here? We have a new dynamic that involves TAS, ADAR, MSL, MPA. At the end of the day? Who is your most essential person on this team. I saw a few posts back that said that TAS were not needed, and I can only laugh at that. Maybe the TAS in your area are not effective, or just plain don’t work. Not in our area. Our TAS has well established relationships and has helped get others connected with key stakeholders in the office.

    MSLs will also be necessary to disseminate information that is not on label when requested.

    The increase in hiring ADARs and ARMs wasn‘t necessarily needed as much as it was to get rid of or retrain the ones that you have to be like the effective ones. I’ve had both kinds, and when you have one that sits at home, and never makes in person visits, good luck with that. Thank goodness they’ve hired one that is the complete opposite and the offices love her. We need the ADARs to close the gap, and yes the SKILL of selling is necessary, even though they aren’t selling the product.

    MPAs. I’m mixed about the value they will have. Agreed that they were effective at their prior ISS role, but technically if they don’t have prior connections or relationships, they aren’t going to get in to the office/hospital and systems; and therefore may need TAS help to connect with the customers in the key accounts.

    Has anyone else noticed that ABLs aren’t in the CORE 4? it feels like they will eventually get rid of the ABL position, and make them all MPAs. If the company did their due diligence, and retained and hired only top tier TAS, essentially we wouldn’t need an ABL to do field rides and “observe”. This new team concept needs someone to work collaboratively; hence the MPA position becomes more important and it will be about managing and partnering on what needs to be done in the account.

    Just some thoughts that make a lot more sense than having too many layers of leadership.
    Click to expand...
    Thanks, I’m interviewing for one of the field based CORE 4 Vice Presidents positions in Milwaukee-Madison today.
    Anyone of yous have any idea if the Volvo XC 90 in leather is on the car selector list? Also can I stay in J W Marriott or Hyatt’s Park level hotels and can I keep the hotel, airline, car rental, and credit card points I earn?
    thanks as I uasally invite my partner on all my business trips, little vacations yous know. This is my third interview and I’ve been told I’m recieving the offer today! I’m so excited to join the team!!!!!!!!!!

So EXCITED
May 20, 2025 at 12:29 PM
Core 4 - Novartis

  • Things that make you go hmmm.

    Does anyone else see what is going on here? We have a new dynamic that involves TAS, ADAR, MSL, MPA. At the end of the day? Who is your most essential person on this team. I saw a few posts back that said that TAS were not needed, and I can only laugh at that. Maybe the TAS in your area are not effective, or just plain don’t work. Not in our area. Our TAS has well established relationships and has helped get others connected with key stakeholders in the office.

    MSLs will also be necessary to disseminate information that is not on label when requested.

    The increase in hiring ADARs and ARMs wasn‘t necessarily needed as much as it was to get rid of or retrain the ones that you have to be like the effective ones. I’ve had both kinds, and when you have one that sits at home, and never makes in person visits, good luck with that. Thank goodness they’ve hired one that is the complete opposite and the offices love her. We need the ADARs to close the gap, and yes the SKILL of selling is necessary, even though they aren’t selling the product.

    MPAs. I’m mixed about the value they will have. Agreed that they were effective at their prior ISS role, but technically if they don’t have prior connections or relationships, they aren’t going to get in to the office/hospital and systems; and therefore may need TAS help to connect with the customers in the key accounts.

    Has anyone else noticed that ABLs aren’t in the CORE 4? it feels like they will eventually get rid of the ABL position, and make them all MPAs. If the company did their due diligence, and retained and hired only top tier TAS, essentially we wouldn’t need an ABL to do field rides and “observe”. This new team concept needs someone to work collaboratively; hence the MPA position becomes more important and it will be about managing and partnering on what needs to be done in the account.

    Just some thoughts that make a lot more sense than having too many layers of leadership.

anonymous
May 20, 2025 at 12:13 PM
Karyopharm - oncology - Biotech Startups

  • our clown show rolls to conf tomorrow to waste more money................another swing and a miss

anonymous
May 20, 2025 at 12:13 PM
Top Bottom
Back
Post thread…